Literature DB >> 31975751

Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States.

George Grunberger1, David Sze2, Anastasia Ermakova2, Ray Sieradzan2, Teresa Oliveria2, Eden M Miller3.   

Abstract

An online survey was conducted to assess the perspectives and use of diabetes technologies by a sample of U.S. primary care physicians (PCPs) and endocrinologists to optimize intensive insulin therapy in patients with type 2 diabetes. Overall, endocrinologists reported using diabetes technologies more frequently than PCPs for patients with type 2 diabetes requiring basal-bolus insulin therapy. PCPs and endocrinologists who were highly focused on diabetes management with insulin therapy reported using insulin delivery devices (insulin pumps and wearable tube-free patches) when patients are not achieving their A1C target while taking basal plus three or more prandial injections of insulin daily.
© 2019 by the American Diabetes Association.

Entities:  

Year:  2020        PMID: 31975751      PMCID: PMC6969667          DOI: 10.2337/cd19-0008

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


  19 in total

1.  CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO(®) DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN.

Authors:  Rosemarie Lajara; Jaime A Davidson; Carla C Nikkel; Tracy L Morris
Journal:  Endocr Pract       Date:  2016-02-01       Impact factor: 3.443

2.  Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force.

Authors:  George Grunberger; Jill M Abelseth; Timothy S Bailey; Bruce W Bode; Yehuda Handelsman; Richard Hellman; Lois Jovanovič; Wendy S Lane; Philip Raskin; William V Tamborlane; Caitlin Rothermel
Journal:  Endocr Pract       Date:  2014-05       Impact factor: 3.443

3.  Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.

Authors:  Lin Xie; Steve Zhou; Brett W Pinsky; Erin K Buysman; Onur Baser
Journal:  Diabetes Technol Ther       Date:  2014-04-15       Impact factor: 6.118

4.  Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System.

Authors:  Rosemarie Lajara; Dianne A Fetchick; Tracy L Morris; Carla Nikkel
Journal:  Diabetes Ther       Date:  2015-10-15       Impact factor: 2.945

5.  Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.

Authors:  R Aronson; Y Reznik; I Conget; J A Castañeda; S Runzis; S W Lee; O Cohen
Journal:  Diabetes Obes Metab       Date:  2016-03-22       Impact factor: 6.577

Review 6.  Gaps and barriers in the control of blood glucose in people with type 2 diabetes.

Authors:  Lawrence Blonde; Pablo Aschner; Clifford Bailey; Linong Ji; Lawrence A Leiter; Stephan Matthaei
Journal:  Diab Vasc Dis Res       Date:  2017-02-01       Impact factor: 3.291

7.  Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial.

Authors: 
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

8.  Aspects of insulin treatment.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

9.  Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study.

Authors:  Ram Weiss; Satish K Garg; Bruce W Bode; Timothy S Bailey; Andrew J Ahmann; Kenneth A Schultz; John B Welsh; John J Shin
Journal:  Diabetes Technol Ther       Date:  2015-06-02       Impact factor: 6.118

Review 10.  Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors.

Authors:  William H Polonsky; Robert R Henry
Journal:  Patient Prefer Adherence       Date:  2016-07-22       Impact factor: 2.711

View more
  2 in total

1.  CRS Diabetes: An Effective Model for Improving Family Medicine Resident Knowledge, Competence, and Performance in Diabetes Care.

Authors:  Nora A Williams; Stephen A Brunton; Gregory A Scott
Journal:  Clin Diabetes       Date:  2022-01

2.  Determining the Perception and Willingness of Primary Care Providers to Prescribe Advanced Diabetes Technologies.

Authors:  Alexander O'Donovan; Sean M Oser; Jessica Parascando; Arthur Berg; Donald E Nease; Tamara K Oser
Journal:  J Patient Cent Res Rev       Date:  2021-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.